A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1994
11/15/1994	US5364757 Methods of supporting a diagnosis of systemic lupus erythematosus
11/15/1994	US5364756 Method of cryopreserving a suspension of biological material
11/15/1994	US5364624 Inhibitors of human leukocyte elastase, treatment of cystic fibrosis
11/15/1994	US5364613 Polychelants containing macrocyclic chelant moieties
11/15/1994	US5364612 Detection of cardiovascular lesions
11/15/1994	CA1333048C Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
11/11/1994	CA2123144A1 Stabilisation of pharmacologically active compounds in sustained release compositions
11/10/1994	WO1994025627A1 Methods of treating and detecting cancer using viruses
11/10/1994	WO1994025616A1 Cell-targeted lytic pore-forming agents
11/10/1994	WO1994025602A1 Hepatitis-c virus type 4, 5 and 6
11/10/1994	WO1994025601A2 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994	WO1994025600A1 Recombinant antigens from mumps virus and their use in vaccines
11/10/1994	WO1994025599A1 Mammal cell lines and method of obtaining glycoproteins
11/10/1994	WO1994025598A2 Methods and compositions for salmonella-based vaccines
11/10/1994	WO1994025597A2 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA)
11/10/1994	WO1994025596A2 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS
11/10/1994	WO1994025594A2 Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii
11/10/1994	WO1994025573A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
11/10/1994	WO1994025491A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	WO1994025489A1 Downregulation of allergen-specific immune response
11/10/1994	WO1994025488A1 Method for preparing a metal-radionuclide-labelled protein
11/10/1994	WO1994025486A1 Improved hcv diagnostic agents
11/10/1994	WO1994025474A1 3-(aminoacyl-amino)-saccharides and method for preparing them
11/10/1994	WO1994025429A1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs
11/10/1994	WO1994025066A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
11/10/1994	WO1994025065A1 Immunizing agent and an affinity-chromatography support including the agent
11/10/1994	WO1994025064A1 Hepatitis c virus cell propagation and related methods
11/10/1994	WO1994025063A1 Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific t cell populations
11/10/1994	WO1994025060A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
11/10/1994	WO1994025054A1 Recombinant vaccine
11/10/1994	WO1994025047A1 Inhibition of leukocyte adhesion
11/10/1994	WO1994025044A1 Calcitonin gene-related peptide-induced tolerance
11/10/1994	WO1994025005A1 Lyospheres comprising gonadotropin
11/10/1994	WO1994025000A1 Hookworm anticoagulant
11/10/1994	WO1994021812A3 Hepatitis b escape mutant specific binding molecules
11/10/1994	WO1994021800A3 Protein tyrosine phosphatase ptp-s31
11/10/1994	WO1994021781A3 Extracellular signal-regulated kinase, sequences, and methods of production and use
11/10/1994	WO1994021656A3 Novel phospholipid-saccharide conjugates
11/10/1994	CA2662090A1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994	CA2162157A1 Polyoxime compounds and their preparation
11/10/1994	CA2161796A1 Hookworm anticoagulant
11/10/1994	CA2161772A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	CA2161671A1 Methods of treating and detecting cancer using viruses
11/10/1994	CA2161656A1 Combined treatment of iron depletion and igg antibody
11/10/1994	CA2161645A1 Recombinant antigens from mumps virus and their use in vaccines
11/10/1994	CA2161534A1 Immunogenic formulation of ospc antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
11/10/1994	CA2161517A1 Mammalian cell lines and method of obtaining glycoproteins
11/10/1994	CA2161405A1 Methods and compositions for detection of salmonella
11/10/1994	CA2161404A1 Methods and compositions for salmonella-based vaccines
11/10/1994	CA2161316A1 Downregulation of allergen-specific immune response
11/10/1994	CA2161114A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
11/10/1994	CA2160909A1 Cell-targeted lytic pore-forming agents
11/10/1994	CA2141739A1 Method for preparing a metal-radionuclide-labelled protein
11/09/1994	EP0623676A1 Metalloproteinase inhibitor
11/09/1994	EP0623675A1 Altered affinity polypeptides of metal chelate binding antibodies
11/09/1994	EP0623674A1 Interleukin-1 receptors
11/09/1994	EP0623352A2 Bifunctional glycoproteins having a modified carbohydrate complement, and their use in tumorselective therapy
11/09/1994	EP0623351A1 Topical pharmaceutical compositions containing antianthracycline monoclonal antibodies
11/09/1994	EP0623216A1 IMMUNOCHEMICAL DETECTION OF $i(IN VIVO) ADVANCED GLYCOSYLATION ENDPRODUCTS
11/09/1994	EP0623215A1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis
11/09/1994	EP0623173A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1
11/09/1994	EP0623172A1 Marek's disease virus recombinant poxvirus vaccine
11/09/1994	EP0623170A1 Vaccines based on streptokinase
11/09/1994	EP0623169A1 Hepatitis e virus vaccine and method
11/09/1994	EP0623168A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
11/09/1994	EP0623167A1 Preparation of mystery disease virus antigens and vaccines and antigens and vaccines produced for the prevention of this disease
11/09/1994	EP0623147A1 A major histocompatibility complex class ii antigen in a vaccine against an immunodeficiency virus
11/09/1994	EP0623026A1 Detoxified lps-cholera toxin conjugate vaccine for prevention of cholera
11/09/1994	EP0623025A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
11/09/1994	EP0420937B1 Therapeutic compositions for the treatment of myocardial infarction
11/09/1994	EP0152477B1 Polypeptide-induced monoclonal antibodies to oncoproteins
11/09/1994	CN1094640A Urease-based vaccine against helicobacter infection
11/08/1994	US5362643 Immunoglobulin chains with bound antibodies for immunology
11/08/1994	US5362641 Hydrolytic enzymes
11/08/1994	US5362491 Modified biologically active protein composition
11/08/1994	CA2121927A1 Method of determination of pivka of every kind and reagent therefor
11/08/1994	CA1332919C Viral vaccine
11/02/1994	EP0622458A2 Adrenomedullin
11/02/1994	EP0622456A1 Prokaryotic and eukaryotic vectors producing polypeptides containing epitopes of PDGF B
11/02/1994	EP0622084A1 Antibody-drug conjugates
11/02/1994	EP0622081A2 Epitopic regions of phneumococcal surface protein A
11/02/1994	EP0621899A1 Expression signal-peptide-free staphylokinases.
11/02/1994	EP0621898A1 Chimeric immunogens
11/02/1994	EP0621893A1 Feline leukemia virus vaccines
11/02/1994	EP0621875A1 Fibrinogen binding protein
11/02/1994	EP0621874A1 Somatostatin receptors
11/02/1994	EP0621868A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus
11/02/1994	EP0621790A1 Attenuated, live vaccine for delaware strain ibdv
11/02/1994	EP0621786A1 Induced tolerance to xenografts
11/02/1994	EP0621780A1 Methods for using histamine derivatives as immunomodulators and in immunotherapeutics
11/02/1994	EP0506714B1 Matrix with adherently bound cells and process for producing viruses/virus antigens
11/02/1994	EP0426667B1 Composition for macrophage activation
11/02/1994	EP0396560B1 Process for increasing the growth rate and/or utilization of fodder or foodstuffs and/or resistance in animals and humans
11/02/1994	EP0367757B1 Co-vaccination using non-o-carbohydrate side-chain gram-negative bacteria preparation
11/02/1994	CN1094446A ECK receptor ligands
11/02/1994	CN1094445A Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/02/1994	CN1094311A Hepatitis B surface antigen albumen with front surface antigen definitive group on the amino terminal
11/01/1994	US5360897 Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
11/01/1994	US5360736 Propagating in and harvesting from a cell culture varicella zoster virus under conditions which maximize virus yield and stability
11/01/1994	US5360735 DNA encoding a human 5-HT1F receptor, vectors, and host cells

1 ... 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 ... 1823